Reviewed,
UniProtKB/Swiss-Prot Q13425 (SNTB2_HUMAN)
Last modified
November 24, 2009.
Version 102.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Beta-2-syntrophin Alternative name(s): 59 kDa dystrophin-associated protein A1 basic component 2 Syntrophin-3 Short name=SNT3 Syntrophin-like Short name=SNTL | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 540 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Adapter protein that binds to and probably organizes the subcellular localization of a variety of membrane proteins. May link various receptors to the actin cytoskeleton and the dystrophin glycoprotein complex. May play a role in the regulation of secretory granules via its interaction with PTPRN. |
| Subunit structure | Monomer and homodimer Probable. Interacts with the other members of the syntrophin family: SNTA1 and SNTB1; and with the sodium channel proteins SCN4A and SCN5A. Interacts with SAST, MAST205, microtubules and microtubule-associated proteins By similarity. Interacts with the dystrophin protein DMD and related proteins DTNA and UTRN, and with the neuroregulin receptor ERBB4. Interacts with PTPRN when phosphorylated, protecting PTPRN from protein cleavage by CAPN1. Dephosphorylation upon insulin stimulation disrupts the interaction with PTPRN and results in the cleavage of PTPRN. |
| Subcellular location | Membrane. Cytoplasmic vesicle › secretory vesicle membrane; Peripheral membrane protein. Cell junction By similarity. Cytoplasm › cytoskeleton. Note: Membrane-associated. In muscle, it is exclusively localized at the neuromuscular junction By similarity. In insulinoma cell line, it is enriched in secretory granules. |
| Tissue specificity | Ubiquitous. Isoform 1 is the predominant isoform. Weak level of isoform 2 is present in all tested tissues, except in liver and heart where it is highly expressed. |
| Domain | The PH 1 domain mediates the oligomerization in a calcium dependent manner By similarity. The PDZ domain binds to the last three or four amino acids of ion channels and receptor proteins. The association with dystrophin or related proteins probably leaves the PDZ domain available to recruit proteins to the membrane By similarity. The SU domain binds calmodulin in a calcium-dependent manner By similarity. |
| Post-translational modification | Phosphorylated. Partially dephosphorylated upon insulin stimulation. Ref.7 Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 |
| Sequence similarities | Belongs to the syntrophin family. Contains 1 PDZ (DHR) domain. Contains 2 PH domains. Contains 1 SU (syntrophin unique) domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| P83954 | 1 | EBI-80411,EBI-368317 | From a different organism. | |
| DMD | P11532 | 1 | EBI-80411,EBI-295827 | |
| PTPRN | Q16849 | 1 | EBI-80411,EBI-728153 | |
| PTPRN | Q16849 | 2 | EBI-289697,EBI-728153 | |
| UTRN | P46939 | 1 | EBI-80411,EBI-295856 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q13425-1) Also known as: Beta2-syntrophin58; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q13425-2) Also known as: Beta2-syntrophin28; The sequence of this isoform differs from the canonical sequence as follows: 266-267: LI → QN 268-540: Missing. | ||||||
| Note: Lacks domains required for interaction with dystrophin related proteins. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 540 | 540 | Beta-2-syntrophin | PRO_0000184011 | ||||||||||||||||||||
Regions | ||||||||||||||||||||||||
| Domain | 115 – 198 | 84 | PDZ | |||||||||||||||||||||
| Domain | 163 – 300 | 138 | PH 1 | |||||||||||||||||||||
| Domain | 325 – 437 | 113 | PH 2 | |||||||||||||||||||||
| Domain | 484 – 540 | 57 | SU | |||||||||||||||||||||
| Region | 518 – 540 | 23 | Calmodulin-binding By similarity | |||||||||||||||||||||
| Compositional bias | 54 – 57 | 4 | Poly-Ala | |||||||||||||||||||||
| Compositional bias | 66 – 69 | 4 | Poly-Ala | |||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||
| Modified residue | 95 | 1 | Phosphoserine Ref.7 Ref.8 Ref.11 Ref.12 | |||||||||||||||||||||
| Modified residue | 110 | 1 | Phosphoserine Ref.7 Ref.10 Ref.11 Ref.12 | |||||||||||||||||||||
| Modified residue | 201 | 1 | Phosphothreonine Ref.9 | |||||||||||||||||||||
| Modified residue | 222 | 1 | Phosphoserine Ref.10 Ref.12 | |||||||||||||||||||||
| Modified residue | 233 | 1 | Phosphoserine Ref.7 | |||||||||||||||||||||
| Modified residue | 393 | 1 | Phosphoserine Ref.7 Ref.10 Ref.12 | |||||||||||||||||||||
| Modified residue | 395 | 1 | Phosphoserine | |||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||
| Alternative sequence | 266 – 267 | 2 | LI → QN in isoform 2. | VSP_006358 | ||||||||||||||||||||
| Alternative sequence | 268 – 540 | 273 | Missing in isoform 2. | VSP_006359 | ||||||||||||||||||||
| Natural variant | 424 | 1 | D → E: dbSNP rs1058482. | VAR_014076 | ||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||
| Beta strand | 113 – 119 | 7 | ||||||||||||||||||||||
| Beta strand | 127 – 133 | 7 | ||||||||||||||||||||||
| Helix | 134 – 136 | 3 | ||||||||||||||||||||||
| Beta strand | 138 – 145 | 8 | ||||||||||||||||||||||
| Helix | 150 – 154 | 5 | ||||||||||||||||||||||
| Beta strand | 161 – 166 | 6 | ||||||||||||||||||||||
| Helix | 176 – 184 | 9 | ||||||||||||||||||||||
| Beta strand | 188 – 196 | 9 | ||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives." Ahn A.H., Feener C.A., Gussoni E., Yoshida M., Ozawa E., Kunkel L.M. J. Biol. Chem. 271:2724-2730(1996) [PubMed: 8576247] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH DMD; DTNA AND UTRN. Tissue: Muscle. |
| [2] | "The receptor tyrosine phosphatase-like protein ICA512 binds the PDZ domains of beta2-syntrophin and nNOS in pancreatic beta-cells." Ort T., Maksimova E., Dirkx R., Kachinsky A.M., Berghs S., Froehner S.C., Solimena M. Eur. J. Cell Biol. 79:621-630(2000) [PubMed: 11043403] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), INTERACTION WITH PTPRN. Tissue: Brain. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Mammary gland. |
| [4] | "The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses." Garcia R.A., Vasudevan K., Buonanno A. Proc. Natl. Acad. Sci. U.S.A. 97:3596-3601(2000) [PubMed: 10725395] [Abstract] Cited for: INTERACTION WITH ERBB4. |
| [5] | "Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated cleavage of ICA512 upon stimulation of insulin secretion." Ort T., Voronov S., Guo J., Zawalich K., Froehner S.C., Zawalich W., Solimena M. EMBO J. 20:4013-4023(2001) [PubMed: 11483505] [Abstract] Cited for: INTERACTION WITH PTPRN. |
| [6] | "An unappreciated role for RNA surveillance." Hillman R.T., Green R.E., Brenner S.E. Genome Biol. 5:R8.1-R8.16(2004) [PubMed: 14759258] [Abstract] Cited for: SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S). |
| [7] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95; SER-110; SER-233 AND SER-393, MASS SPECTROMETRY. Tissue: Epithelium. |
| [8] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, MASS SPECTROMETRY. Tissue: Epithelium. |
| [9] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-201, MASS SPECTROMETRY. Tissue: Epithelium. |
| [10] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110; SER-222 AND SER-393, MASS SPECTROMETRY. |
| [11] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95 AND SER-110, MASS SPECTROMETRY. |
| [12] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95; SER-110; SER-222 AND SER-393, MASS SPECTROMETRY. |
| [13] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [14] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95; SER-110 AND SER-395, MASS SPECTROMETRY. |
| [15] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95; SER-110 AND SER-393, MASS SPECTROMETRY. Tissue: T-cell. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U40572 mRNA. Translation: AAC50449.1. AF243385 mRNA. Translation: AAK15149.1. BC048215 mRNA. Translation: AAH48215.1. | |||||||||||||
| IPI | IPI00009505. IPI00216631. | ||||||||||||
| RefSeq | NP_006741.1. | ||||||||||||
| UniGene | Hs.461117 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q13425. 7 interactions. | ||||||||||||
| STRING | Q13425. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q13425. | ||||||||||||
Proteomic databases | |||||||||||||
| PeptideAtlas | Q13425. | ||||||||||||
| PRIDE | Q13425. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000336278; ENSP00000338191; ENSG00000168807; Homo sapiens. [Genome view] | ||||||||||||
| GeneID | 6645. | ||||||||||||
| KEGG | hsa:6645. | ||||||||||||
| NMPDR | fig|9606.3.peg.12469. | ||||||||||||
| UCSC | uc002ewu.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 6645. | ||||||||||||
| GeneCards | GC16P067778. | ||||||||||||
| H-InvDB | HIX0026942. | ||||||||||||
| HGNC | HGNC:11169. SNTB2. | ||||||||||||
| HPA | HPA001394. | ||||||||||||
| MIM | 600027. gene. | ||||||||||||
| PharmGKB | PA36009. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOGENOM | Q13425. | ||||||||||||
| HOVERGEN | Q13425. | ||||||||||||
| OMA | TRATKAG | ||||||||||||
| OrthoDB | EOG95F07S | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q13425. | ||||||||||||
| Bgee | Q13425. | ||||||||||||
| CleanEx | HS_SNTB2. | ||||||||||||
| Genevestigator | Q13425. | ||||||||||||
| GermOnline | ENSG00000168807. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR001478. PDZ/DHR/GLGF. IPR001849. Pleckstrin_homology. IPR015482. Syntrophin. [Graphical view] | ||||||||||||
| PANTHER | PTHR10554. Syntrophin. 1 hit. | ||||||||||||
| Pfam | PF00595. PDZ. 1 hit. PF00169. PH. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00228. PDZ. 1 hit. SM00233. PH. 2 hits. [Graphical view] | ||||||||||||
| PROSITE | PS50106. PDZ. 1 hit. PS50003. PH_DOMAIN. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 25895. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | SNTB2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q13425 Secondary accession number(s): Q9BY09 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


